Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Primary Tumor Research and Outcomes Network
NCT02790983 · View on ClinicalTrials.gov ↗
Study Summary
This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.
Conditions Studied
Study Locations (19)
Other
- University of Queensland, School of Medicine — Brisbane
- Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden — Dresden
- National Center for Spinal Disorders and Buda Health Center — Budapest
- Istituto Ortopedico Rizzoli — Bologna
- IRCCS Istituto Ortopedico Galeazzi — Milan
- Kanazawa Medical University Hospital — Kanazawa
- Oxford University Hospitals — Oxford
California
- University of California — Los Angeles
- UCSF Medical Center — San Francisco
New York
- Memorial Sloan-Kettering Cancer Center — New York
- Memorial Sloan Kettering Cancer Center — New York
Maryland
- Johns Hopkins University School of Medicine — Baltimore
Massachusetts
- Massachusetts General Hospital — Boston
Minnesota
- Mayo Clinic — Rochester
Rhode Island
- Rhode Island Hospital — Providence
Texas
- The University of Texas M.D. Anderson Cancer Center — Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2016-10 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02790983
The ClinicalTrials.gov registry entry for NCT02790983 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 13 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Spinal Column Tumor appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02790983 reports 19 study locations spanning 11 distinct geographic areas — top geographies include Other, California, New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02790983 about?
NCT02790983 is a clinical study titled "Primary Tumor Research and Outcomes Network". This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinica...
What is the current status of trial NCT02790983?
This trial is currently recruiting. The enrollment target is 1,350 participants. The study started on 2016-10. Estimated completion is 2028-12.
What conditions does trial NCT02790983 study?
This clinical trial studies the following conditions: Spinal Column Tumor. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT02790983?
This trial is sponsored by AO Innovation Translation Center, which has 13 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02790983 being conducted?
This trial has 19 study locations across California, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.